Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

AGM Statement

3 Jun 2010 07:00

RNS Number : 9687M
Empresaria Group PLC
03 June 2010
 



3 June 2010

 

Empresaria Group plc

 

AGM Statement

 

 

 

At today's Annual General Meeting of Empresaria Group plc ("Empresaria" or "the Group"), the international specialist staffing group, the Board will make the following statement:

 

Group strategy is to develop an international specialist staffing group balanced by geography and sector and with a strong emphasis on temporary staffing operations. There are two drivers behind this strategy; to gain access to higher growth economies and staffing markets, and to reduce the risks inherent in cyclical markets and volatile economies through diversification and focus on more stable revenue streams.

 

Our focus on developing markets and economies alleviated some of the downward pressure on revenues and margins in 2009 and is now demonstrating its benefit in 2010. Revenues, net fee income and profit for the Group are materially ahead of last year and ahead of Board expectations with all three reporting regions showing year on year growth.

 

Revenues for the current financial year to April, excluding discontinued operations, are 17% up on the same period in 2009 and net fee income is up 24% on the same period. These volume increases are driven largely by growth in temporary staffing revenues in the UK and Germany along with growing demand for a combination of staffing and HR services offered by Group companies in Asia, particularly for corporate training and Recruitment Process Outsourcing solutions. In addition, the UK operations have experienced an increase in permanent recruitment activity, a trend that may well be more transitory given the uncertainty as to the outlook for the UK economy.

 

Group profitability is much improved as a consequence of higher sales volumes, improved gross margin percentages and the effect of cost reductions made in the UK and Continental Europe during 2009. In addition, the Group is now benefiting from increased profit contribution from its rapidly maturing and fast growing portfolio of Asian companies that commenced trading as start up operations over recent years. Although the Board remains cautious as to the outlook for the global economy, it now expects full year profits to be materially ahead of current market expectations.

 

 

 

For further information contact:

Miles Hunt

Chief Executive, Empresaria Group plc

01293 649 900

Spencer Wreford

Finance Director, Empresaria Group plc

01293 649 900

Claes Spang

Singer Capital Markets Limited

020 3205 7500

 

 

 

 

 

 

 

 

Notes for editors:

 

About Empresaria

 

*Empresaria operates out of 16 countries and approximately 120 offices and has over 800 internal staff. 

*65% of the Group's net fee income is generated outside the UK, and approximately 80% of net fee income is generated from temporary and contract business 

*Empresaria applies a management equity philosophy and business model with each group company management team holding significant equity in its own business

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSAFLEFSSELM
Date   Source Headline
7th Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSPDMR Dealing, Exercise of Share Options
22nd Aug 20237:00 amRNSInterim Results
15th Aug 20237:00 amRNSLaunch of LMA Recruitment in the US
27th Jul 20237:00 amRNSTrading Update and Notice of Results
19th Jun 20238:20 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
23rd May 20231:18 pmRNSResult of AGM
23rd May 20237:00 amRNSTrading Update
16th May 20237:00 amRNSTransaction in Own Shares
2nd May 20236:25 pmRNSDirector/PDMR Shareholding
2nd May 20234:26 pmRNSTransaction in Own Shares
28th Apr 20233:50 pmRNSPDMR Dealing, Exercise of Share Options
26th Apr 20237:00 amRNSCompany LTIP Awards
20th Apr 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
30th Mar 202310:15 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSFinal Results
20th Mar 20233:05 pmRNSNotice of Investor Presentation
20th Feb 20237:00 amRNSAppointment of Independent Non-Executive Director
26th Jan 20237:00 amRNSTrading Update
16th Jan 20237:00 amRNSAppointment of Independent Non-Executive Director
15th Dec 20222:49 pmRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
12th Dec 20227:18 amRNSTransaction in Own Shares
7th Dec 20228:34 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSAppointment of Joint Broker
9th Nov 20228:24 amRNSTransaction in Own Shares
4th Nov 20227:00 amRNSTransaction in Own Shares
24th Oct 20227:00 amRNSDirector/PDMR Shareholding
14th Oct 20223:25 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSCapital Markets Day
6th Oct 20225:10 pmRNSTransaction in Own Shares
4th Oct 20228:13 amRNSTransaction in Own Shares
1st Sep 202212:23 pmRNSTransaction in Own Shares
12th Aug 20227:00 amRNSTransaction in Own Shares
11th Aug 20227:00 amRNSInterim Results
28th Jul 20227:00 amRNSTrading Update and Notice of Results
20th Jun 202210:54 amRNSTransaction in Own Shares
14th Jun 20229:16 amRNSTransaction in Own Shares
7th Jun 202211:44 amRNSDirector/PDMR Shareholding
7th Jun 202211:37 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSBoard Update
18th May 20221:40 pmRNSTransaction in Own Shares
17th May 20228:33 amRNSTransaction in Own Shares
12th May 20224:11 pmRNSResult of AGM
12th May 20223:20 pmRNSTransaction in Own Shares
12th May 20227:00 amRNSTrading Update
11th May 20225:09 pmRNSTransaction in Own Shares
10th May 20222:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.